Suppr超能文献

通过T细胞受体刺激在未成熟人CD4⁺FOXP3⁺ T细胞中诱导FOXP3表达是转化生长因子-β依赖性的,但不会赋予调节性表型。

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.

作者信息

Tran Dat Q, Ramsey Heather, Shevach Ethan M

机构信息

Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Blood. 2007 Oct 15;110(8):2983-90. doi: 10.1182/blood-2007-06-094656. Epub 2007 Jul 20.

Abstract

Thymic-derived natural T-regulatory cells (nTregs) are important for the induction of self-tolerance and the control of autoimmunity. Murine CD4+CD25(-)Foxp3(-) cells can be induced to express Foxp3 after T-cell receptor (TCR) activation in the presence of transforming growth factor beta (TGFbeta) and are phenotypically similar to nTregs. Some studies have suggested that TCR stimulation of human CD4+CD25(-) cells results in the induction of transient expression of FOXP3, but that the induced cells lack a regulatory phenotype. We demonstrate here that TCR stimulation alone was insufficient to induce FOXP3 expression in the absence of TGFbeta, whereas high levels of FOXP3 expression could be induced in the presence of TGFbeta. Although FOXP3 expression was stable, the TGFbeta-induced FOXP3+ T cells were neither anergic nor suppressive and produced high levels of effector cytokines. These results suggest that even high levels of FOXP3 expression are insufficient to define a human CD4+ T cell as a T-regulatory cell.

摘要

胸腺来源的天然T调节细胞(nTregs)对于诱导自身耐受和控制自身免疫至关重要。在转化生长因子β(TGFβ)存在的情况下,小鼠CD4 + CD25(-)Foxp3(-)细胞在T细胞受体(TCR)激活后可被诱导表达Foxp3,并且在表型上与nTregs相似。一些研究表明,TCR刺激人CD4 + CD25(-)细胞会导致FOXP3短暂表达的诱导,但诱导的细胞缺乏调节表型。我们在此证明,在没有TGFβ的情况下,单独的TCR刺激不足以诱导FOXP3表达,而在TGFβ存在的情况下可以诱导高水平的FOXP3表达。尽管FOXP3表达稳定,但TGFβ诱导的FOXP3 + T细胞既无反应性也无抑制性,并且产生高水平的效应细胞因子。这些结果表明,即使高水平的FOXP3表达也不足以将人CD4 + T细胞定义为T调节细胞。

相似文献

3
Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.
PLoS One. 2012;7(1):e29355. doi: 10.1371/journal.pone.0029355. Epub 2012 Jan 17.
5
Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Arthritis Res Ther. 2011 Jun 27;13(3):R106. doi: 10.1186/ar3387.
8
A dynamic dual role of IL-2 signaling in the two-step differentiation process of adaptive regulatory T cells.
J Immunol. 2013 Apr 1;190(7):3153-62. doi: 10.4049/jimmunol.1200751. Epub 2013 Feb 20.
10
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
Int Immunol. 2007 Apr;19(4):345-54. doi: 10.1093/intimm/dxm014. Epub 2007 Feb 27.

引用本文的文献

1
Coupling IL-2 with IL-10 to mitigate toxicity and enhance antitumor immunity.
Cell Rep Med. 2025 Aug 19;6(8):102257. doi: 10.1016/j.xcrm.2025.102257. Epub 2025 Jul 30.
4
High Antigenicity for T Cells Confers Resistance to PD-1 Blockade Therapy via High PD-1 Expression in T Cells.
Cancer Sci. 2025 May;116(5):1214-1226. doi: 10.1111/cas.70029. Epub 2025 Feb 27.
5
Elusive modes of Foxp3 activity in versatile regulatory T cells.
Front Immunol. 2025 Jan 15;15:1533823. doi: 10.3389/fimmu.2024.1533823. eCollection 2024.
6
Regulation of human Th9 cell differentiation by lipid modulators targeting PPAR-γ and acetyl-CoA-carboxylase 1.
Front Immunol. 2024 Dec 23;15:1509408. doi: 10.3389/fimmu.2024.1509408. eCollection 2024.
7
CD137-expressing regulatory T cells in cancer and autoimmune diseases.
Mol Ther. 2025 Jan 8;33(1):51-70. doi: 10.1016/j.ymthe.2024.12.010. Epub 2024 Dec 11.
8
Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations.
Front Immunol. 2024 Sep 3;15:1457189. doi: 10.3389/fimmu.2024.1457189. eCollection 2024.
9
Tregs in transplantation tolerance: role and therapeutic potential.
Front Transplant. 2023 Aug 30;2:1217065. doi: 10.3389/frtra.2023.1217065. eCollection 2023.
10
Regulatory T Cells: Therapeutic Opportunities in Uveitis.
Front Ophthalmol (Lausanne). 2022 May 25;2:901144. doi: 10.3389/fopht.2022.901144. eCollection 2022.

本文引用的文献

2
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
Nature. 2007 Apr 5;446(7136):685-9. doi: 10.1038/nature05673. Epub 2007 Mar 21.
3
Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells.
J Immunol. 2007 Apr 1;178(7):4022-6. doi: 10.4049/jimmunol.178.7.4022.
4
FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4571-6. doi: 10.1073/pnas.0700298104. Epub 2007 Mar 7.
5
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
Int Immunol. 2007 Apr;19(4):345-54. doi: 10.1093/intimm/dxm014. Epub 2007 Feb 27.
6
Regulatory T cell development in the absence of functional Foxp3.
Nat Immunol. 2007 Apr;8(4):359-68. doi: 10.1038/ni1445. Epub 2007 Feb 2.
7
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
Nature. 2007 Feb 15;445(7129):766-70. doi: 10.1038/nature05479. Epub 2007 Jan 14.
8
Foxp3-dependent programme of regulatory T-cell differentiation.
Nature. 2007 Feb 15;445(7129):771-5. doi: 10.1038/nature05543. Epub 2007 Jan 14.
9
Transient regulatory T-cells: a state attained by all activated human T-cells.
Clin Immunol. 2007 Apr;123(1):18-29. doi: 10.1016/j.clim.2006.10.014. Epub 2006 Dec 19.
10
Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.
Eur J Immunol. 2007 Jan;37(1):129-38. doi: 10.1002/eji.200636435.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验